Behavioral Intervention

High-Intensity Interval Training for HIV/AIDS

University of Alabama at Birmingham, Birmingham, AL
Targeting 3 different conditionsHigh-Intensity Interval Training +1 moreN/AWaitlist AvailableLed by Raymond Jones, Ph.D.Research Sponsored by University of Alabama at Birmingham

Study Summary

This trial will study if exercise can help people 50+ living with HIV who have suboptimal cognition. 60 participants in Alabama will be monitored over 3 months to measure the effects of exercise.

Eligible Conditions
  • Arterial Stiffness
  • Cognitive Impairment

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You are not physically active and do less than 150 minutes of moderate exercise per week, as determined by a questionnaire.
You have difficulty thinking, learning, or remembering things, which is assessed using a test called BRACE+.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 12 weeks, 3-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 12 weeks, 3-months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cognitive function
Change in vascular function
Secondary outcome measures
Barriers to Engagement in Exercise
Perceptions of the Study and Exercise Interventions
Other outcome measures
Participant Safety, Adherence to the Intervention, Retention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-Intensity Interval TrainingExperimental Treatment1 Intervention
Group II: Continuous Moderate ExerciseActive Control1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
High-Intensity Interval Training

Find a site

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,509 Previous Clinical Trials
2,256,911 Total Patients Enrolled
Raymond Jones, Ph.D.Principal Investigator
University of Alabama at Birmingham

Media Library

Continuous Moderate Exercise (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05965518 — N/A
HIV/AIDS Research Study Groups: High-Intensity Interval Training, Continuous Moderate Exercise
HIV/AIDS Clinical Trial 2023: Continuous Moderate Exercise Highlights & Side Effects. Trial Name: NCT05965518 — N/A
Continuous Moderate Exercise (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05965518 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this exploration actively calling for new participants?

"According to the details posted on, this specific medical investigation is not admitting patients presently. The protocol for enrollment was first published in September of 2023 and last revised at the end of July that year; however, there are still 836 other studies recruiting participants right now."

Answered by AI
~40 spots leftby Dec 2027